Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines

Summary

Our recent studies on breast carcinoma cell lines with differing tumorigenicity / invasiveness (MCF-7< MDA-MB-468< MDAMB-231< MDA-MB-435) had shown significantly decreasing expression levels of MMPs-1,-2,-3,-8,-9,-10,-11 and –13 with increasing cell density while the levels of TIMP-1 and –2 increased. This correlated well with a lower invasiveness of confluent cells. In the present study, we extend our in vitro studies on three-dimensional cultures of breast cancer cell lines MCF-7 and MDAMB-435 and the transcriptional control of MMP and TIMP-expression in two-dimensional cultures of MDA-MB-231 and –435 cells. The tumor spheroid model showed that MMP expression and proteolytic activity were considerably higher in loosely structured tumor groups as compared to densely growing “compact” cell complexes. These data suggested that cell density regulates MMP and TIMP transcription and therefore, we tested whether AP-1, NFκB and CRE are involved in this process. Gene silencing of c-jun in sparse cultures had an inhibitory effect on MMP-3,–9 and –13 expression, on proteolytic activity as well as on the invasive potential of the cells, thus confirming a role for AP-1. TIMP-1, and –2 expression was up-regulated as compared to control cells. Consistent with this, overexpression of c-jun and c-fos in confluent breast cancer cell lines leads to up-regulation of MMP expression, proteolytic activity and invasion as well as down-regulation of TIMP-1. In summary, we provide evidence that cell density influences the invasive potential of tumor cells via regulation of MMPs and TIMPs by AP-1, NFκB and CRE transcription factors. Overexpression of MMPs in sparse cultures could help explain early dissemination of potentially metastatic cells.

Keywords

Breast cancer cell lines - MMP-regulation - gene silencing - invasion - cell density

Partly presented at the Second Chianti Meeting on Proteases held in Tuscany, Italy, from May 16–20, 2004

• References

• 1 Stetler-Stevenson WG, Yu AE. Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001; 11: 143-52.
• 2 Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
• 3 Henriet P, Blavier L, Declerck YA. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation APMIS. 1999; 107: 111-109
• 4 Yoshizaki T, Maruyama Y, Sato H. et al. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 2001; 95: 44-50.
• 5 Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regu- lation, signal transduction and cell-type-specific expression. Methods Mol Biol 2001; 151: 121-48.
• 6 Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-92.
• 7 Bergman MR, Cheng S, Honbo N. et al. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunBFosB heterodimers. Biochem J 2003; 369: 485-96.
• 8 Takahra T, Smart DE, Oakley F. et al. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int J Biochem Cell Biol 2004; 36: 353-63.
• 9 Menashi S, Dehem M, Souliac I. et al. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells. Int J Cancer 1998; 75: 259-65.
• 10 Igarashi T, Abe M, Oikawa M. et al. Retinoic acids repress the expression of ETS-1 in endothelial cells. Tohoku J Exp Med 2001; 194: 35-43.
• 11 Bachmeier BE, Nerlich AG, Boukamp P. et al. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1, -8, and –13 and of TIMP-1. Biol Chem 2000; 381: 509-16.
• 12 Bachmeier BE, Boukamp P, Lichtinghagen R. et al. Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 2000; 381: 497-507.
• 13 Meade-Tollin LC, Boukamp P, Fusenig NE. et al. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes. Br J Cancer 1998; 77: 724-30.
• 14 Bachmeier BE, Nerlich AG, Lichtinghagen R. et al. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 2001; 21: 3821-8.
• 15 Benbow U, Schoenermark MP, Orndorff KA. et al. Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by alltrans retinoic acid. Clin Exp Metastasis 1999; 17: 231-8.
• 16 Balduyck M, Zerimech F, Gouyer V. et al. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 2000; 18: 171-8.
• 17 Lebeau A, Muller-Aufdemkamp C, Allmacher C. et al. Cellular protein and mRNA expression patterns of matrix metalloproteinases–2, –3 and –9 in human breast cancer: Correlation with tumour growth. J Mol Histol 2004; 35: 443-55.
• 18 Bachmeier BE, Rohrbach H, DeWaal J. et al. Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas. Int J Oncol 2004; 00: 1-13.
• 18 Bachmeier BE, Albini A, Vene R. et al. Cell denisity- dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. Exp Cell Res 2005. in press
• 19 Price JE, Polyzos A, Zhang RD. et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717-21.
• 20 Zhang RD, Fidler IJ, Price JE. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991; 11: 204-15.
• 21 Soule HD, Vazguez J, Long A. et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409-16.
• 22 Kobayashi K, Rochat A, Barrandon Y. Segregation of keratinocyte colony-forming cells in the bulge of the rat vibrissa. Proc Natl Acad Sci USA 1993; 90: 7391-5.
• 23 Mayer B, Klement G, Kaneko M. et al. Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 2001; 121: 839-52.
• 24 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem 1987; 162: 156-9.
• 25 Nakada M, Nakamura H, Ikeda E. et al. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 1999; 154: 417-28.
• 26 Minami R, Tsunoda H, Iijima T. et al. Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix. Mod Pathol 2003; 16: 1164-70.
• 27 Albini A. Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 1998; 4: 230-41.
• 28 Albini A, Iwamoto Y, Kleinman HK. et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
• 29 Kleinman HK, McGarvey ML, Hassell JR. et al. Basement membrane complexes with biological activity. Biochemistry 1986; 25: 312-8.
• 30 Netzker R, Weigert C, Brand K. Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. Eur J Biochem 1997; 245: 174-81.
• 31 Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol 1997; 15: 519-26.
• 32 Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001; 20: 438-52.
• 33 Kossakowska AE, Huchcroft SA, Urbanski SJ. et al. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996; 73: 1401-8.
• 34 Airola K, Karonen T, Vaalamo M. et al. Expression of collagenases-1 and –3 and their inhibitors TIMP-1 and –3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999; 80: 733-43.
• 35 Murray GI, Duncan ME, O'Neil P. et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996; 2: 461-2.
• 36 Tetu B, Brisson J, Lapointe H. et al. Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer. Hum Pathol 1998; 29: 979-85.
• 37 Nakopoulou L, Giannopoulou I, Gakiopoulou H. et al. Matrix metalloproteinase-1 and –3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999; 30: 436-42.
• 38 Garbett EA, Reed MW, Brown NJ. Proteolysis in human breast and colorectal cancer. Br J Cancer 1999; 81: 287-93.
• 39 Benbow U, Rutter JL, Lowrey CH. et al. Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter. Br J Cancer 1999; 79: 221-08
• 40 Azzam HS, Arand G, Lippman ME. et al. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 1993; 85: 1758-64.
• 41 Pardo A, Barrios R, Maldonado V. et al. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 1998; 153: 833-44.
• 42 Hasan S, Nakajima M. Retinoic acid synergizes with cyclic AMP to enhance MMP-2 basal promoter activity. Biochem Biophys Res Commun 1999; 258: 663-7.
• 43 Paal E, Thompson LD, Przygodzki RM. et al. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Mod Pathol 1999; 12: 518-28.
• 44 Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131-E136.
• 45 Smith LM, Wise SC, Hendricks DT. et al. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 1999; 18: 6063-70.
• 46 Angel P, Baumann I, Stein B. et al. 12-O-tetradecanoyl- phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region. Mol Cell Biol 1987; 7: 2256-66.
• 47 Kirstein M, Sanz L, Quinones S. et al. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J Biol Chem 1996; 271: 18231-6.
• 48 Rutter JL, Benbow U, Coon I C. et al. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 1997; 66: 322-36.
• 49 Xie B, Bucana CD, Fidler IJ. Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am J Pathol 1994; 144: 1058-67.
• 50 Behrens P, Rothe M, Wellmann A. et al. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 2001; 194: 43-50.
• 51 Yabe H, Fukuma M, Urano F. et al. Lack of matrix metalloproteinase (MMP)–1 and –3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo. Biochem Biophys Res Commun 2002; 293: 61-71.
• 52 Hotary KB, Allen ED, Brooks PC. et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33-45.
• 53 Hagedorn H, Schreiner M, Wiest I. et al. Defective basement membrane in laryngeal carcinomas with heterogeneous loss of distinct components. Hum Pathol 1998; 29: 447-54.
• 54 Klein CA. The systemic progression of human cancer: a focus on the individual disseminated cancer cell--the unit of selection. Adv Cancer Res 2003; 89: 35-67.
• 55 Schmidt-Kittler O, Ragg T, Daskalakis A. et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003; 100: 7737-42.
• 56 Bernards R, Weinberg RA. A progression puzzle. Nature 2002; 418: 823